jueves, 20 de julio de 2017

Final Research Plan: Medication Use for the Risk Reduction of Primary Breast Cancer in Women

Final Research Plan: Breast Cancer: Medications for Risk Reduction - US Preventive Services Task Force
U.S. Preventive Services Task Force banner
July 20, 2017 – The U.S. Preventive Services Task Force posted today a final 
research plan on medication use for the risk reduction of primary breast 
cancer in women. The draft research plan for this topic was posted for public 
comment from 3/23/17 to 4/16/17. The Task Force reviewed all of the comments 
that were submitted and took them into consideration as it finalized the 
research plan. To view the final research plan, please 
go to https://www.uspreventiveservicestaskforce.org/Page/Document/final-research-plan/breast-cancer-medications-for-risk-reduction1.
Figure 1 is a flow diagram of selection of candidates for medications to reduce the risk for primary breast cancer. Women without preexisting breast cancer are screened and sorted into either appropriate or inappropriate candidates for therapy. Women who are appropriate candidates for therapy receive medications to reduce the risk for primary breast cancer. Women may experience adverse effects due to these medications. Women who are treated with these medications may have reduced incidence of invasive or noninvasive breast cancer, which may lead to improved breast cancer-related mortality and all-cause mortality.

No hay comentarios: